Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. (Q50502507)
Jump to navigation
Jump to search
scientific article published in February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results. |
scientific article published in February 2012 |
Statements
Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results (English)